Daniel L. Hogan

2.0k total citations
62 papers, 1.6k citations indexed

About

Daniel L. Hogan is a scholar working on Gastroenterology, Surgery and Molecular Biology. According to data from OpenAlex, Daniel L. Hogan has authored 62 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Gastroenterology, 29 papers in Surgery and 14 papers in Molecular Biology. Recurrent topics in Daniel L. Hogan's work include Gastroesophageal reflux and treatments (31 papers), Helicobacter pylori-related gastroenterology studies (25 papers) and Gastrointestinal motility and disorders (10 papers). Daniel L. Hogan is often cited by papers focused on Gastroesophageal reflux and treatments (31 papers), Helicobacter pylori-related gastroenterology studies (25 papers) and Gastrointestinal motility and disorders (10 papers). Daniel L. Hogan collaborates with scholars based in United States, Australia and Denmark. Daniel L. Hogan's co-authors include Jon I. Isenberg, Michael A. Koss, John A. Selling, Mark Ainsworth, K.E. McArthur, Anthony I. Stern, Kevin L. Kraemer, Gilbert H. Smith, Vijaya S. Pratha and Klaus Bukhave and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Gastroenterology.

In The Last Decade

Daniel L. Hogan

60 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel L. Hogan United States 24 728 603 450 209 192 62 1.6k
S. J. Rune Denmark 23 923 1.3× 658 1.1× 213 0.5× 101 0.5× 258 1.3× 68 1.6k
Daniel H. Winship United States 25 990 1.4× 729 1.2× 331 0.7× 120 0.6× 307 1.6× 49 2.2k
Mitchell L. Schubert United States 29 1.1k 1.4× 654 1.1× 578 1.3× 67 0.3× 274 1.4× 98 2.3k
P. G. Burhol Norway 25 1.2k 1.7× 643 1.1× 366 0.8× 114 0.5× 212 1.1× 157 2.3k
János Lonovics Hungary 27 965 1.3× 185 0.3× 344 0.8× 104 0.5× 117 0.6× 66 1.7k
Kenneth G. Mandel United States 11 330 0.5× 293 0.5× 728 1.6× 42 0.2× 145 0.8× 19 1.5k
Joseph D. Fondacaro United States 20 305 0.4× 180 0.3× 300 0.7× 82 0.4× 149 0.8× 52 1.3k
W. Krömer Germany 21 342 0.5× 385 0.6× 611 1.4× 72 0.3× 76 0.4× 72 1.4k
Onesmo B. Balemba United States 23 299 0.4× 354 0.6× 416 0.9× 80 0.4× 94 0.5× 44 1.3k
Yuyuan Li China 27 455 0.6× 259 0.4× 651 1.4× 57 0.3× 100 0.5× 100 1.9k

Countries citing papers authored by Daniel L. Hogan

Since Specialization
Citations

This map shows the geographic impact of Daniel L. Hogan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel L. Hogan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel L. Hogan more than expected).

Fields of papers citing papers by Daniel L. Hogan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel L. Hogan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel L. Hogan. The network helps show where Daniel L. Hogan may publish in the future.

Co-authorship network of co-authors of Daniel L. Hogan

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel L. Hogan. A scholar is included among the top collaborators of Daniel L. Hogan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel L. Hogan. Daniel L. Hogan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Pratha, Vijaya S., et al.. (2006). Intravenous Pantoprazole as Initial Treatment in Patients With Gastroesophageal Reflux Disease and a History of Erosive Esophagitis: A Randomized Clinical Trial. Digestive Diseases and Sciences. 51(9). 1595–1601. 4 indexed citations
3.
Pratha, Vijaya S., Daniel L. Hogan, James R. Lane, et al.. (2006). Inhibition of Pentagastrin-Stimulated Gastric Acid Secretion by Pantoprazole and Omeprazole in Healthy Adults. Digestive Diseases and Sciences. 51(1). 123–131. 12 indexed citations
4.
Sellers, Zachary M., Jimmy Y. C. Chow, Daniel L. Hogan, et al.. (2004). Heat-stable enterotoxin ofEscherichia colistimulates a non-CFTR-mediated duodenal bicarbonate secretory pathway. American Journal of Physiology-Gastrointestinal and Liver Physiology. 288(4). G654–G663. 25 indexed citations
5.
Pratha, Vijaya S., Stephen M. Thompson, Daniel L. Hogan, et al.. (1998). Utility of endoscopic biopsy samples to quantitate human duodenal ion transport. Journal of Laboratory and Clinical Medicine. 132(6). 512–518. 16 indexed citations
6.
Amelsberg, A., et al.. (1996). Cyclic Adenosine-3′,5′-Monophosphate Production Is Greater in Rabbit Duodenal Crypt Than in Villus Cells. Scandinavian Journal of Gastroenterology. 31(3). 233–239. 14 indexed citations
7.
Knutson, Tina W., Michael A. Koss, Daniel L. Hogan, Jon I. Isenberg, & Lars Knutson. (1995). Acetazolamide inhibits basal and stimulated HCO3− secretion in the human proximal duodenum. Gastroenterology. 108(1). 102–107. 22 indexed citations
8.
Ainsworth, Mark, Michael A. Koss, Daniel L. Hogan, & J. I. Isenberg. (1995). Higher proximal duodenal mucosal bicarbonate secretion is independent of Brunner's glands in rats and rabbits. Gastroenterology. 109(4). 1160–1166. 18 indexed citations
9.
Hogan, Daniel L., et al.. (1995). Histamine inhibits prostaglandin E2-stimulated rabbit duodenal bicarbonate secretion via H2 receptors and enteric nerves. Gastroenterology. 108(6). 1676–1682. 9 indexed citations
11.
Hogan, Daniel L., et al.. (1993). The enteric nervous system modulates mammalian duodenal mucosal bicarbonate secretion. Gastroenterology. 105(2). 410–417. 41 indexed citations
12.
Hussein, Ziad, G. Richard Granneman, Emil Samara, et al.. (1993). Age‐related differences in the pharmacokinetics and pharmacodynamics of lansoprazole. British Journal of Clinical Pharmacology. 36(5). 391–398. 39 indexed citations
13.
Odes, H.S., et al.. (1992). Measurement of Gastric Bicarbonate Secretion in the Human Stomach: Different Methods Produce Discordant Results. Scandinavian Journal of Gastroenterology. 27(10). 829–836. 20 indexed citations
14.
Sanders, Steven W., et al.. (1991). Effect of Basal Gastric Acid Secretion on the Pharmacodynamics of Ranitidine. Chronobiology International. 8(3). 186–193. 5 indexed citations
15.
Isenberg, Jon I. & Daniel L. Hogan. (1990). Human duodenal mucosal bicarbonate secretion—physiological and clinical aspects. Journal of Internal Medicine. 228(S732). 113–117. 6 indexed citations
16.
Odes, H.S., et al.. (1990). Human duodenal mucosal bicarbonate secretion. Gastroenterology. 98(4). 867–872. 46 indexed citations
17.
Bukhave, Klaus, J Rask-Madsen, Daniel L. Hogan, Michael A. Koss, & Jon I. Isenberg. (1990). Proximal duodenal prostaglandin E2 release and mucosal bicarbonate secretion are altered in patients with duodenal ulcer. Gastroenterology. 99(4). 951–955. 51 indexed citations
18.
Thomas, F., et al.. (1989). The Effect of Vasoactive Intestinal Peptide, Secretin, and Glucagon on Human Duodenal Bicarbonate Secretion. Scandinavian Journal of Gastroenterology. 24(2). 151–157. 30 indexed citations
19.
Hogan, Daniel L.. (1988). Damage and protection of the human gastric mucosa. The American Journal of Medicine. 84(2). 35–40. 8 indexed citations
20.
Thomas, Frank J., Michael A. Koss, Daniel L. Hogan, & Jon I. Isenberg. (1986). Enprostil, a synthetic prostaglandin E2 analogue, inhibits meal-stimulated gastric acid secretion and gastrin release in patients with duodenal ulcer. The American Journal of Medicine. 81(2). 44–49. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026